Three new prescription diet drugs for the obese on FDA roadmap

More info…
(ChattahBox) Three companies each have a weight-loss drug in the final stages of development, and the race is on to get their drug applications into the FDA for review. Obesity researchers say the drugs by companies Vivus, Arena Pharmaceuticals, and Orexigen, which will not be available to the public for at least a year, could help curb weight-related diseases such as diabetes, heart disease, stroke, and some cancers. Those 30 pounds or more over a healthy weight, who took one of the medicat

cocaine rehab

Share and Enjoy:
  • Digg
  • Twitter
  • Facebook
  • del.icio.us
  • NewsVine
  • Reddit
  • StumbleUpon
  • LinkedIn
  • BlinkList
  • Propeller
  • Technorati
  • email

Speak Your Mind

*

Security Code: